170 related articles for article (PubMed ID: 27917902)
1. Association of MTDH immunohistochemical expression with metastasis and prognosis in female reproduction malignancies: a systematic review and meta-analysis.
Hou Y; Yu L; Mi Y; Zhang J; Wang K; Hu L
Sci Rep; 2016 Dec; 6():38365. PubMed ID: 27917902
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.
Liu Y; Su Z; Li G; Yu C; Ren S; Huang D; Fan S; Tian Y; Zhang X; Qiu Y
Int J Cancer; 2013 Aug; 133(3):671-9. PubMed ID: 23364922
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer.
Tokunaga E; Nakashima Y; Yamashita N; Hisamatsu Y; Okada S; Akiyoshi S; Aishima S; Kitao H; Morita M; Maehara Y
Breast Cancer; 2014 May; 21(3):341-9. PubMed ID: 22903204
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of MTDH and VEGF in triple-negative breast cancer].
Tan L; Qin H; Piao Y; Liu Z; Han Y; Song F; Xie X
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):827-32. PubMed ID: 26887512
[TBL] [Abstract][Full Text] [Related]
5. Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer.
Haug S; Schnerch D; Halbach S; Mastroianni J; Dumit VI; Follo M; Hasenburg A; Köhler M; Dierbach H; Herzog S; Proske A; Werner M; Dengjel J; Brummer T; Laßmann S; Wäsch R; Zeiser R
Int J Cancer; 2015 May; 136(10):2328-40. PubMed ID: 25346496
[TBL] [Abstract][Full Text] [Related]
6. Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition.
Du Y; Jiang B; Song S; Pei G; Ni X; Wu J; Wang S; Wang Z; Yu J
Int J Oncol; 2017 Jul; 51(1):63-74. PubMed ID: 28534938
[TBL] [Abstract][Full Text] [Related]
7. Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.
Jiang M; Lin X; He R; Lin X; Liang L; Tang R; Xiong D; Wei K; Dang Y; Feng Z; Chen G
Med Sci Monit; 2016 Jun; 22():1850-7. PubMed ID: 27246752
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
Liang C; Ding J; Yang Y; Deng L; Li X
Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111
[TBL] [Abstract][Full Text] [Related]
9. A Preliminary Study on Metadherin as a Potential Marker for Progression of Diffuse Large B Cell Lymphoma.
Ge X; Sui X; Fang X; Jiang Y; Ding M; Liu X; Wang X
Genet Test Mol Biomarkers; 2018 Aug; 22(8):481-486. PubMed ID: 30117777
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.
Tian SB; Tao KX; Hu J; Liu ZB; Ding XL; Chu YN; Cui JY; Shuai XM; Gao JB; Cai KL; Wang JL; Wang GB; Wang L; Wang Z
Sci Rep; 2017 Nov; 7(1):15500. PubMed ID: 29138453
[TBL] [Abstract][Full Text] [Related]
11. High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers.
Peng L; Yuan XQ; Liu ZY; Li WL; Zhang CY; Zhang YQ; Pan X; Chen J; Li YH; Li GC
Oncotarget; 2017 Jan; 8(1):1655-1667. PubMed ID: 27926484
[TBL] [Abstract][Full Text] [Related]
12. Metadherin regulates radioresistance in cervical cancer cells.
Zhao Y; Moran MS; Yang Q; Liu Q; Yuan C; Hong S; Kong B
Oncol Rep; 2012 May; 27(5):1520-6. PubMed ID: 22367022
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
Yu J; Wang JG; Zhang L; Yang HP; Wang L; Ding D; Chen Q; Yang WL; Ren KH; Zhou DM; Zou Q; Jin YT; Liu XP
Oncotarget; 2016 Jun; 7(25):38612-38625. PubMed ID: 27229534
[TBL] [Abstract][Full Text] [Related]
14. The MTDH (-470G>A) polymorphism is associated with ovarian cancer susceptibility.
Yuan C; Li X; Yan S; Yang Q; Liu X; Kong B
PLoS One; 2012; 7(12):e51561. PubMed ID: 23240043
[TBL] [Abstract][Full Text] [Related]
15. Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.
Mizrak Kaya D; Dong X; Nogueras-González GM; Xu Y; Estrella JS; Harada K; Lopez A; Amlashi FG; Hofstetter WL; Maru DM; Nguyen QN; Lee JH; Weston B; Bhutani MS; Erasmus JJ; Thomas I; Rogers JE; Song S; Ajani JA
Med Oncol; 2017 Aug; 34(8):135. PubMed ID: 28685276
[TBL] [Abstract][Full Text] [Related]
16. Metadherin overexpression in perihilar cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.
Zhu YZ; Zhou K; Ruan LL; Sun F; Wang G; Li WF
Oncol Lett; 2019 May; 17(5):4514-4520. PubMed ID: 30988817
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
[TBL] [Abstract][Full Text] [Related]
18. Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival.
Zhou J; Li J; Wang Z; Yin C; Zhang W
Asia Pac J Clin Oncol; 2012 Sep; 8(3):e42-8. PubMed ID: 22898150
[TBL] [Abstract][Full Text] [Related]
19. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
[TBL] [Abstract][Full Text] [Related]
20. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
Li W; Zhai L; Zhao C; Lv S
Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
